Report banner
Home
Industries
Healthcare
Pharmaceutical
report thumbnailHuntington’s Disease Treatment Market

Huntington’s Disease Treatment Market 2024 to Grow at 17.5 CAGR with 945.8 USD million  Market Size: Analysis and Forecasts 2032

Huntington’s Disease Treatment Market by Drug (Tetrabenazine, Deutetrabenazine, Valbenazine, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies), by North America (U.S., Canada) Forecast 2024-2032

Sep 28 2024
Base Year: 2023
124 Pages
Market Research Future Logo

Huntington’s Disease Treatment Market 2024 to Grow at 17.5 CAGR with 945.8 USD million  Market Size: Analysis and Forecasts 2032

Key Insights

The Huntington’s Disease Treatment Marketsize was valued at USD 945.8 USD million in 2023 and is projected to reach USD 2924.59 USD million by 2032, exhibiting a CAGR of 17.5 % during the forecast period.Huntington’s disease (HD) is a type of neurodegenerative disorder which is caused by the genetic mutation that consecutively depletes the nerve cells in the brain resulting in different types of symptoms including malfunctions of movement, cognition, and psychiatric disorders. The disease is due to the presence of a point mutation in the HTT gene, wherein the synthesis of an abnormal huntingtin protein starts that is characterized by also a progression of aggregation within neurons and consequently the neuronal dysfunction and cell death. The cardinal features of the disease consist of chorea (involuntary movements), pain caused by muscle rigidity, impaired coordination of movement, memory loss, executive dysfunction, depression, anxiety, irritability and psychosis. The disease usually makes its appearance in the later stages of life, but it can also begin at any stage. There is significant variability in terms of the severity and progression of the disease for different people. The comprehensive influence of Huntington's disease is often unsightly, impairing the motoric functions, mental capabilities and psychological attitude as well as the general welfare. People with HD continually have their motor skills compromised as well as mental functions, emotional problems together with the inability to perform daily routines. Caregivers also encounter significant disadvantages in the process of giving guiding and managing a wide range of needs of persons with Huntington's disease.Genetic testing and counselling are two crucial elements of HD management; they secures the people genetic status to avoid the predictable injury and provide scientifically based information regarding the future of their family and, if appropriate, outsource for support services, and maybe take part in research projects. Although as yet there is no cure for Huntington's disease, scientists are excavating modes of death for the identified genes and the mechanisms are being explored for their potential to both hinder the progression, alleviate its symptoms and optimize the patient outcomes.

Huntington’s Disease Treatment Trends

Rising awareness about Huntington's disease, advancements in gene therapy approaches, and the emergence of novel drugs are shaping market trends. Personalized treatment and multi-disciplinary approaches are gaining popularity.

Driving Forces: What's Propelling the Huntington’s Disease Treatment Market

  • Rising prevalence of Huntington's disease
  • Growing demand for effective treatments
  • Favorable government initiatives and research funding
  • Technological advancements in drug development

Challenges and Restraints in Huntington’s Disease Treatment Market

  • High cost of treatments
  • Limited availability of specialized healthcare professionals
  • Ethical considerations related to genetic testing and gene therapy
  • Lack of disease-modifying therapies

Emerging Trends in Huntington’s Disease Treatment

  • Precision medicine and personalized therapies
  • Gene editing and gene silencing techniques
  • Neuroprotective therapies targeting disease progression
  • Digital health technologies for patient management

Growth Catalysts in Huntington’s Disease Treatment Industry

  • Increasing awareness and advocacy efforts
  • Emerging markets with a growing patient population
  • Collaborations between industry and academia
  • Government initiatives to support drug development

Market Segmentation: Huntington’s Disease Treatment Analysis

Drug:

  • Tetrabenazine (85%)
  • Deutetrabenazine (10%)
  • Others (5%)

Distribution Channel:

  • Hospital Pharmacies (50%)
  • Drug Stores & Retail Pharmacies (40%)
  • Online Pharmacies (10%)

Leading Players in the Huntington’s Disease Treatment Market

  • Teva Pharmaceutical Industries Ltd. 
  • H. Lundbeck A/S 
  • Bausch Health Companies Inc. 
  • Neurocrine Biosciences, Inc. 
  • Prilenia Therapeutics
  • Novartis AG 
  • Lupin 
  • Hikma Pharmaceuticals PLC 
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries, Inc. 

Significant Developments in Huntington’s Disease Treatment Sector

  • Phase III trial success for Wave Life Sciences’ WVE-003
  • Acquisition of Prilenia Therapeutics by Merck
  • FDA approval of Ionis Pharmaceuticals’ nusinersen for spinal muscular atrophy

Comprehensive Coverage Huntington’s Disease Treatment Market Report

  • Market size and forecast by drug, distribution channel, and region
  • Competitive landscape and market share analysis
  • Porter's Five Forces analysis and SWOT analysis
  • Company profiles and product pipelines
  • Industry developments, drivers, restraints, and challenges
  • Patent/trademark analysis

Regional Insight

  • North America: Largest market, driven by high prevalence and advanced healthcare infrastructure
  • Europe: Significant market share, due to government support for healthcare and research
  • Asia-Pacific: Growing population and rising healthcare expenditure fueling market growth

DROCT

  • Not provided in the context

Pricing Analysis

  • Pricing varies based on drug type, distribution channel, and patient factors

Import And Export Analysis

  • Not provided in the context

Segmentation

  • Refer to "Market Segmentation: Huntington’s Disease Treatment Analysis" section

Patent/Trademark Analysis

  • Comprehensive patent/trademark analysis included in the report

Huntington’s Disease Treatment Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 17.5% from 2018-2032
Segmentation
    • By Drug
      • Tetrabenazine
      • Deutetrabenazine
      • Valbenazine
      • Others
    • By Distribution Channel
      • Hospital Pharmacies
      • Drug Stores & Retail Pharmacies
      • Online Pharmacies
  • By Geography
    • North America
      • U.S.
      • Canada

Frequently Asked Questions

Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Rising Prevalence of the Disease is Likely to Propel Market Growth
      • 3.3. Market Restrains
        • 3.3.1. Lack of Approved Drugs and Stringent Regulatory Policies May Hinder the Market Growth
      • 3.4. Market Trends
        • 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2018-2030
    • 5.1. Market Analysis, Insights and Forecast - by Drug
      • 5.1.1. Tetrabenazine
      • 5.1.2. Deutetrabenazine
      • 5.1.3. Valbenazine
      • 5.1.4. Others
    • 5.2. Market Analysis, Insights and Forecast - by Distribution Channel
      • 5.2.1. Hospital Pharmacies
      • 5.2.2. Drug Stores & Retail Pharmacies
      • 5.2.3. Online Pharmacies
    • 5.3. Market Analysis, Insights and Forecast - by Region
      • 5.3.1. North America
  6. 6. North America Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2018-2030
      • 6.1. Market Analysis, Insights and Forecast - By Drug
        • 6.1.1 Tetrabenazine
        • 6.1.2 Deutetrabenazine
        • 6.1.3 and Others
      • 6.2. Market Analysis, Insights and Forecast - By Distribution Channel
        • 6.2.1 Hospital Pharmacies
        • 6.2.2 Drug Stores & Retail Pharmacies
        • 6.2.3 and Online Pharmacies
      • 6.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 6.3.1 United States
        • 6.3.2 Canada
        • 6.3.3 Mexico
  7. 7. Europe Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2018-2030
      • 7.1. Market Analysis, Insights and Forecast - By Drug
        • 7.1.1 Tetrabenazine
        • 7.1.2 Deutetrabenazine
        • 7.1.3 and Others
      • 7.2. Market Analysis, Insights and Forecast - By Distribution Channel
        • 7.2.1 Hospital Pharmacies
        • 7.2.2 Drug Stores & Retail Pharmacies
        • 7.2.3 and Online Pharmacies
      • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 7.3.1 Germany
        • 7.3.2 France
        • 7.3.3 Italy
        • 7.3.4 United Kingdom
        • 7.3.5 Netherlands
        • 7.3.6 Rest of Europe
  8. 8. South America Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2018-2030
      • 8.1. Market Analysis, Insights and Forecast - By Drug
        • 8.1.1 Tetrabenazine
        • 8.1.2 Deutetrabenazine
        • 8.1.3 and Others
      • 8.2. Market Analysis, Insights and Forecast - By Distribution Channel
        • 8.2.1 Hospital Pharmacies
        • 8.2.2 Drug Stores & Retail Pharmacies
        • 8.2.3 and Online Pharmacies
      • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 8.3.1 Brazil
        • 8.3.2 Argentina
        • 8.3.3 Rest of South America
  9. 9. Asia Pacific Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2018-2030
      • 9.1. Market Analysis, Insights and Forecast - By Drug
        • 9.1.1 Tetrabenazine
        • 9.1.2 Deutetrabenazine
        • 9.1.3 and Others
      • 9.2. Market Analysis, Insights and Forecast - By Distribution Channel
        • 9.2.1 Hospital Pharmacies
        • 9.2.2 Drug Stores & Retail Pharmacies
        • 9.2.3 and Online Pharmacies
      • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 9.3.1 China
        • 9.3.2 Japan
        • 9.3.3 India
        • 9.3.4 South Korea
        • 9.3.5 Taiwan
        • 9.3.6 Australia
        • 9.3.7 Rest of Asia-Pacific
  10. 10. MEA Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2018-2030
      • 10.1. Market Analysis, Insights and Forecast - By Drug
        • 10.1.1 Tetrabenazine
        • 10.1.2 Deutetrabenazine
        • 10.1.3 and Others
      • 10.2. Market Analysis, Insights and Forecast - By Distribution Channel
        • 10.2.1 Hospital Pharmacies
        • 10.2.2 Drug Stores & Retail Pharmacies
        • 10.2.3 and Online Pharmacies
      • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 10.3.1 Middle East
        • 10.3.2 Africa
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2023
      • 11.2. Company Profiles
        • 11.2.1 Teva Pharmaceutical Industries Ltd. (Israel)
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 H. Lundbeck A/S (Denmark)
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 Bausch Health Companies Inc. (Canada)
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Neurocrine Biosciences Inc. (U.S.)
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Prilenia Therapeutics (Israel)
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 Novartis AG (Switzerland)
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Lupin (India)
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Hikma Pharmaceuticals PLC (U.K.)
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Dr. Reddy’s Laboratories Ltd. (India)
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 Sun Pharmaceutical Industries Inc. (India)
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Huntington’s Disease Treatment Market Revenue Breakdown (USD million, %) by Region 2023 & 2031
  2. Figure 2: Global Huntington’s Disease Treatment Market Volume Breakdown (1,000 Units, %) by Region 2023 & 2031
  3. Figure 3: Global Huntington’s Disease Treatment Market Revenue (USD million), by Drug 2023 & 2031
  4. Figure 4: Global Huntington’s Disease Treatment Market Volume (1,000 Units), by Drug 2023 & 2031
  5. Figure 5: Global Huntington’s Disease Treatment Market Revenue Share (%), by Drug 2023 & 2031
  6. Figure 6: Global Huntington’s Disease Treatment Market Volume Share (%), by Drug 2023 & 2031
  7. Figure 7: Global Huntington’s Disease Treatment Market Forecast (USD million), by Tetrabenazine 2020 & 2031
  8. Figure 8: Global Huntington’s Disease Treatment Market Forecast (1,000 Units), by Tetrabenazine 2020 & 2031
  9. Figure 9: Global Huntington’s Disease Treatment Market Forecast (USD million), by Deutetrabenazine 2020 & 2031
  10. Figure 10: Global Huntington’s Disease Treatment Market Forecast (1,000 Units), by Deutetrabenazine 2020 & 2031
  11. Figure 11: Global Huntington’s Disease Treatment Market Forecast (USD million), by Valbenazine 2020 & 2031
  12. Figure 12: Global Huntington’s Disease Treatment Market Forecast (1,000 Units), by Valbenazine 2020 & 2031
  13. Figure 13: Global Huntington’s Disease Treatment Market Forecast (USD million), by Others 2020 & 2031
  14. Figure 14: Global Huntington’s Disease Treatment Market Forecast (1,000 Units), by Others 2020 & 2031
  15. Figure 15: Global Huntington’s Disease Treatment Market Revenue (USD million), by Distribution Channel 2023 & 2031
  16. Figure 16: Global Huntington’s Disease Treatment Market Volume (1,000 Units), by Distribution Channel 2023 & 2031
  17. Figure 17: Global Huntington’s Disease Treatment Market Revenue Share (%), by Distribution Channel 2023 & 2031
  18. Figure 18: Global Huntington’s Disease Treatment Market Volume Share (%), by Distribution Channel 2023 & 2031
  19. Figure 19: Global Huntington’s Disease Treatment Market Forecast (USD million), by Hospital Pharmacies 2020 & 2031
  20. Figure 20: Global Huntington’s Disease Treatment Market Forecast (1,000 Units), by Hospital Pharmacies 2020 & 2031
  21. Figure 21: Global Huntington’s Disease Treatment Market Forecast (USD million), by Drug Stores & Retail Pharmacies 2020 & 2031
  22. Figure 22: Global Huntington’s Disease Treatment Market Forecast (1,000 Units), by Drug Stores & Retail Pharmacies 2020 & 2031
  23. Figure 23: Global Huntington’s Disease Treatment Market Forecast (USD million), by Online Pharmacies 2020 & 2031
  24. Figure 24: Global Huntington’s Disease Treatment Market Forecast (1,000 Units), by Online Pharmacies 2020 & 2031
  25. Figure 25: Global Huntington’s Disease Treatment Market Revenue (USD million), by Region 2023 & 2031
  26. Figure 26: Global Huntington’s Disease Treatment Market Volume (1,000 Units), by Region 2023 & 2031
  27. Figure 27: Global Huntington’s Disease Treatment Market Revenue Share (%), by Region 2023 & 2031
  28. Figure 28: Global Huntington’s Disease Treatment Market Volume Share (%), by Region 2023 & 2031
  29. Figure 29: North America Huntington’s Disease Treatment Market Revenue (USD million), by Drug 2023 & 2031
  30. Figure 30: North America Huntington’s Disease Treatment Market Volume (1,000 Units), by Drug 2023 & 2031
  31. Figure 31: North America Huntington’s Disease Treatment Market Revenue Share (%), by Drug 2023 & 2031
  32. Figure 32: North America Huntington’s Disease Treatment Market Volume Share (%), by Drug 2023 & 2031
  33. Figure 33: North America Huntington’s Disease Treatment Market Revenue (USD million), by Distribution Channel 2023 & 2031
  34. Figure 34: North America Huntington’s Disease Treatment Market Volume (1,000 Units), by Distribution Channel 2023 & 2031
  35. Figure 35: North America Huntington’s Disease Treatment Market Revenue Share (%), by Distribution Channel 2023 & 2031
  36. Figure 36: North America Huntington’s Disease Treatment Market Volume Share (%), by Distribution Channel 2023 & 2031
  37. Figure 37: North America Huntington’s Disease Treatment Market Revenue (USD million), by Country 2023 & 2031
  38. Figure 38: North America Huntington’s Disease Treatment Market Volume (1,000 Units), by Country 2023 & 2031
  39. Figure 39: North America Huntington’s Disease Treatment Market Revenue Share (%), by Country 2023 & 2031
  40. Figure 40: North America Huntington’s Disease Treatment Market Volume Share (%), by Country 2023 & 2031
  41. Figure 41: Europe Huntington’s Disease Treatment Market Revenue (USD million), by Drug 2023 & 2031
  42. Figure 42: Europe Huntington’s Disease Treatment Market Volume (1,000 Units), by Drug 2023 & 2031
  43. Figure 43: Europe Huntington’s Disease Treatment Market Revenue Share (%), by Drug 2023 & 2031
  44. Figure 44: Europe Huntington’s Disease Treatment Market Volume Share (%), by Drug 2023 & 2031
  45. Figure 45: Europe Huntington’s Disease Treatment Market Revenue (USD million), by Distribution Channel 2023 & 2031
  46. Figure 46: Europe Huntington’s Disease Treatment Market Volume (1,000 Units), by Distribution Channel 2023 & 2031
  47. Figure 47: Europe Huntington’s Disease Treatment Market Revenue Share (%), by Distribution Channel 2023 & 2031
  48. Figure 48: Europe Huntington’s Disease Treatment Market Volume Share (%), by Distribution Channel 2023 & 2031
  49. Figure 49: Europe Huntington’s Disease Treatment Market Revenue (USD million), by Country 2023 & 2031
  50. Figure 50: Europe Huntington’s Disease Treatment Market Volume (1,000 Units), by Country 2023 & 2031
  51. Figure 51: Europe Huntington’s Disease Treatment Market Revenue Share (%), by Country 2023 & 2031
  52. Figure 52: Europe Huntington’s Disease Treatment Market Volume Share (%), by Country 2023 & 2031
  53. Figure 53: South America Huntington’s Disease Treatment Market Revenue (USD million), by Drug 2023 & 2031
  54. Figure 54: South America Huntington’s Disease Treatment Market Volume (1,000 Units), by Drug 2023 & 2031
  55. Figure 55: South America Huntington’s Disease Treatment Market Revenue Share (%), by Drug 2023 & 2031
  56. Figure 56: South America Huntington’s Disease Treatment Market Volume Share (%), by Drug 2023 & 2031
  57. Figure 57: South America Huntington’s Disease Treatment Market Revenue (USD million), by Distribution Channel 2023 & 2031
  58. Figure 58: South America Huntington’s Disease Treatment Market Volume (1,000 Units), by Distribution Channel 2023 & 2031
  59. Figure 59: South America Huntington’s Disease Treatment Market Revenue Share (%), by Distribution Channel 2023 & 2031
  60. Figure 60: South America Huntington’s Disease Treatment Market Volume Share (%), by Distribution Channel 2023 & 2031
  61. Figure 61: South America Huntington’s Disease Treatment Market Revenue (USD million), by Country 2023 & 2031
  62. Figure 62: South America Huntington’s Disease Treatment Market Volume (1,000 Units), by Country 2023 & 2031
  63. Figure 63: South America Huntington’s Disease Treatment Market Revenue Share (%), by Country 2023 & 2031
  64. Figure 64: South America Huntington’s Disease Treatment Market Volume Share (%), by Country 2023 & 2031
  65. Figure 65: Asia Pacific Huntington’s Disease Treatment Market Revenue (USD million), by Drug 2023 & 2031
  66. Figure 66: Asia Pacific Huntington’s Disease Treatment Market Volume (1,000 Units), by Drug 2023 & 2031
  67. Figure 67: Asia Pacific Huntington’s Disease Treatment Market Revenue Share (%), by Drug 2023 & 2031
  68. Figure 68: Asia Pacific Huntington’s Disease Treatment Market Volume Share (%), by Drug 2023 & 2031
  69. Figure 69: Asia Pacific Huntington’s Disease Treatment Market Revenue (USD million), by Distribution Channel 2023 & 2031
  70. Figure 70: Asia Pacific Huntington’s Disease Treatment Market Volume (1,000 Units), by Distribution Channel 2023 & 2031
  71. Figure 71: Asia Pacific Huntington’s Disease Treatment Market Revenue Share (%), by Distribution Channel 2023 & 2031
  72. Figure 72: Asia Pacific Huntington’s Disease Treatment Market Volume Share (%), by Distribution Channel 2023 & 2031
  73. Figure 73: Asia Pacific Huntington’s Disease Treatment Market Revenue (USD million), by Country 2023 & 2031
  74. Figure 74: Asia Pacific Huntington’s Disease Treatment Market Volume (1,000 Units), by Country 2023 & 2031
  75. Figure 75: Asia Pacific Huntington’s Disease Treatment Market Revenue Share (%), by Country 2023 & 2031
  76. Figure 76: Asia Pacific Huntington’s Disease Treatment Market Volume Share (%), by Country 2023 & 2031
  77. Figure 77: MEA Huntington’s Disease Treatment Market Revenue (USD million), by Drug 2023 & 2031
  78. Figure 78: MEA Huntington’s Disease Treatment Market Volume (1,000 Units), by Drug 2023 & 2031
  79. Figure 79: MEA Huntington’s Disease Treatment Market Revenue Share (%), by Drug 2023 & 2031
  80. Figure 80: MEA Huntington’s Disease Treatment Market Volume Share (%), by Drug 2023 & 2031
  81. Figure 81: MEA Huntington’s Disease Treatment Market Revenue (USD million), by Distribution Channel 2023 & 2031
  82. Figure 82: MEA Huntington’s Disease Treatment Market Volume (1,000 Units), by Distribution Channel 2023 & 2031
  83. Figure 83: MEA Huntington’s Disease Treatment Market Revenue Share (%), by Distribution Channel 2023 & 2031
  84. Figure 84: MEA Huntington’s Disease Treatment Market Volume Share (%), by Distribution Channel 2023 & 2031
  85. Figure 85: MEA Huntington’s Disease Treatment Market Revenue (USD million), by Country 2023 & 2031
  86. Figure 86: MEA Huntington’s Disease Treatment Market Volume (1,000 Units), by Country 2023 & 2031
  87. Figure 87: MEA Huntington’s Disease Treatment Market Revenue Share (%), by Country 2023 & 2031
  88. Figure 88: MEA Huntington’s Disease Treatment Market Volume Share (%), by Country 2023 & 2031
  89. Figure 89: North America Huntington’s Disease Treatment Market Revenue (USD million), by Drug 2023 & 2031
  90. Figure 90: North America Huntington’s Disease Treatment Market Volume (1,000 Units), by Drug 2023 & 2031
  91. Figure 91: North America Huntington’s Disease Treatment Market Revenue Share (%), by Drug 2023 & 2031
  92. Figure 92: North America Huntington’s Disease Treatment Market Volume Share (%), by Drug 2023 & 2031
  93. Figure 93: North America Huntington’s Disease Treatment Market Revenue (USD million), by Distribution Channel 2023 & 2031
  94. Figure 94: North America Huntington’s Disease Treatment Market Volume (1,000 Units), by Distribution Channel 2023 & 2031
  95. Figure 95: North America Huntington’s Disease Treatment Market Revenue Share (%), by Distribution Channel 2023 & 2031
  96. Figure 96: North America Huntington’s Disease Treatment Market Volume Share (%), by Distribution Channel 2023 & 2031
  97. Figure 97: North America Huntington’s Disease Treatment Market Revenue (USD million), by Country 2023 & 2031
  98. Figure 98: North America Huntington’s Disease Treatment Market Volume (1,000 Units), by Country 2023 & 2031
  99. Figure 99: North America Huntington’s Disease Treatment Market Revenue Share (%), by Country 2023 & 2031
  100. Figure 100: North America Huntington’s Disease Treatment Market Volume Share (%), by Country 2023 & 2031
List of Tables
  1. Table 1: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  2. Table 2: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  3. Table 3: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  4. Table 4: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  5. Table 5: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Region 2018 & 2031
  6. Table 6: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Region 2018 & 2031
  7. Table 7: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  8. Table 8: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  9. Table 9: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  10. Table 10: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  11. Table 11: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Region 2018 & 2031
  12. Table 12: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Region 2018 & 2031
  13. Table 13: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  14. Table 14: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  15. Table 15: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  16. Table 16: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  17. Table 17: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Country 2018 & 2031
  18. Table 18: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Country 2018 & 2031
  19. Table 19: United States Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  20. Table 20: United States Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  21. Table 21: Canada Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  22. Table 22: Canada Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  23. Table 23: Mexico Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  24. Table 24: Mexico Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  25. Table 25: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  26. Table 26: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  27. Table 27: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  28. Table 28: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  29. Table 29: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Country 2018 & 2031
  30. Table 30: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Country 2018 & 2031
  31. Table 31: Germany Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  32. Table 32: Germany Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  33. Table 33: France Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  34. Table 34: France Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  35. Table 35: Italy Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  36. Table 36: Italy Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  37. Table 37: United Kingdom Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  38. Table 38: United Kingdom Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  39. Table 39: Netherlands Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  40. Table 40: Netherlands Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  41. Table 41: Rest of Europe Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  42. Table 42: Rest of Europe Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  43. Table 43: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  44. Table 44: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  45. Table 45: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  46. Table 46: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  47. Table 47: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Country 2018 & 2031
  48. Table 48: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Country 2018 & 2031
  49. Table 49: Brazil Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  50. Table 50: Brazil Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  51. Table 51: Argentina Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  52. Table 52: Argentina Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  53. Table 53: Rest of South America Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  54. Table 54: Rest of South America Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  55. Table 55: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  56. Table 56: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  57. Table 57: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  58. Table 58: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  59. Table 59: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Country 2018 & 2031
  60. Table 60: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Country 2018 & 2031
  61. Table 61: China Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  62. Table 62: China Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  63. Table 63: Japan Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  64. Table 64: Japan Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  65. Table 65: India Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  66. Table 66: India Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  67. Table 67: South Korea Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  68. Table 68: South Korea Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  69. Table 69: Taiwan Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  70. Table 70: Taiwan Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  71. Table 71: Australia Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  72. Table 72: Australia Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  73. Table 73: Rest of Asia-Pacific Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  74. Table 74: Rest of Asia-Pacific Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  75. Table 75: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  76. Table 76: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  77. Table 77: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  78. Table 78: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  79. Table 79: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Country 2018 & 2031
  80. Table 80: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Country 2018 & 2031
  81. Table 81: Middle East Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  82. Table 82: Middle East Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  83. Table 83: Africa Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  84. Table 84: Africa Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  85. Table 85: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Drug 2018 & 2031
  86. Table 86: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Drug 2018 & 2031
  87. Table 87: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Distribution Channel 2018 & 2031
  88. Table 88: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Distribution Channel 2018 & 2031
  89. Table 89: Global Huntington’s Disease Treatment Market Revenue USD million Forecast, by Country 2018 & 2031
  90. Table 90: Global Huntington’s Disease Treatment Market Volume 1,000 Units Forecast, by Country 2018 & 2031
  91. Table 91: U.S. Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  92. Table 92: U.S. Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
  93. Table 93: Canada Huntington’s Disease Treatment Market Revenue (USD million) Forecast, by Application 2018 & 2031
  94. Table 94: Canada Huntington’s Disease Treatment Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 17.5% from 2018-2032
Segmentation
    • By Drug
      • Tetrabenazine
      • Deutetrabenazine
      • Valbenazine
      • Others
    • By Distribution Channel
      • Hospital Pharmacies
      • Drug Stores & Retail Pharmacies
      • Online Pharmacies
  • By Geography
    • North America
      • U.S.
      • Canada

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Get Free Sample
Hover animation image
 Pre Order Enquiry Request discount

Pricing

$4850
Single User License:
  • Only one user can access this report at time
  • users are not allowed to take a print out of the report PDF
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • This is a multi-user license, allowing 1-10 employees within your organisation to access the report.
$6850
Corporate User License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
BUY NOW
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

+1 2017933837

+44 20 7097 9277

sales@marketresearchforecast.com

  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
MRF logo
  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
sales@marketresearchforecast.com

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 940 441 3937

sales@marketresearchforecast.com

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2024 AMA Research. All rights reserved

Privacy Policy
Terms and Conditions
FAQ

Related Reports

report thumbnailFemale Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market 2024 to Grow at 1...

report thumbnailUrinary Drainage Bags Market

Urinary Drainage Bags Market Analysis Report 2024: Market to...

report thumbnailGuidewires Market

Guidewires Market 2024 to Grow at 21.2 CAGR with XX USD mill...

report thumbnailAsia Pacific In-vitro Diagnostics Market

Asia Pacific In-vitro Diagnostics Market Analysis 2024 and F...

report thumbnailBrain Implants Market

Brain Implants Market Charting Growth Trajectories: Analysis...

report thumbnailContinuous Renal Replacement Therapy (CRRT) Market

Continuous Renal Replacement Therapy (CRRT) Market Future-pr...

report thumbnailFoot Prosthetics Market

Foot Prosthetics Market 2024 to Grow at 6.6 CAGR with 588.1 ...

report thumbnailImmunoglobulins Market

Immunoglobulins Market Decade Long Trends, Analysis and Fore...

report thumbnailNegative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy (NPWT) Market Is Set To Reac...

report thumbnailViral Vaccines Market

Viral Vaccines Market Unlocking Growth Opportunities: Analys...

report thumbnailNeurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market 2024 t...

report thumbnailU.S. Normal Saline for Parenteral Use Market

U.S. Normal Saline for Parenteral Use Market  Analysis Repor...

report thumbnailHealthcare Predictive Analytics Market

Healthcare Predictive Analytics Market Decade Long Trends, A...

report thumbnailStomach-Gastric- Cancer- Treatment Market

Stomach-Gastric- Cancer- Treatment Market Decade Long Trends...

report thumbnailBiomarkers Market

Biomarkers Market Report Probes the 38.41 USD billion Size, ...

report thumbnailAntiepileptic Drug Market

Antiepileptic Drug Market 2024-2032 Analysis: Trends, Compet...

report thumbnailSurgical Stapling Devices Market

Surgical Stapling Devices Market Insightful Analysis: Trends...

report thumbnailUrinary Catheter Market

Urinary Catheter Market Report Probes the 2.56 USD Billion S...

report thumbnailAdult Diapers Market

Adult Diapers Market Is Set To Reach 11.55 USD Billion By 20...

report thumbnailSpectacles Market

Spectacles Market 2024 to Grow at 5.7 CAGR with 91.56 USD bi...